Brind.

Jack Khattar became CEO of Supernus Pharmaceuticals, and on August 13, 2025, TD Cowen analysts engaged with the company during its earnings call.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Jack Khattar became CEO of Supernus Pharmaceuticals, and on August 13, 2025, TD Cowen analysts engaged with the company during its earnings call.

Who's involved

What this event is mainly about
Supernus Pharmaceuticals (United States)TD Cowen

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • StockStory5 Insightful Analyst Questions From Supernus Pharmaceuticals’s Q2 Earnings Call Supernus Pharmaceuticals delivered a quarter that saw revenue surpass Wall Street’s expectations, despite a year-over-y